Assembly Biosciences, Inc.

NasdaqGS:ASMB 주식 보고서

시가총액: US$95.5m

Assembly Biosciences 관리

관리 기준 확인 3/4

Assembly Biosciences CEO는 Jason Okazaki, Aug2022 에 임명되었습니다 의 임기는 2.25 년입니다. 총 연간 보상은 $ 1.37M, 43.7% 로 구성됩니다. 43.7% 급여 및 56.3% 보너스(회사 주식 및 옵션 포함). 는 $ 200.07K 가치에 해당하는 회사 주식의 0.21% 직접 소유합니다. 200.07K. 경영진과 이사회의 평균 재임 기간은 각각 4 년과 4.8 년입니다.

주요 정보

Jason Okazaki

최고 경영자

US$1.4m

총 보상

CEO 급여 비율43.7%
CEO 임기2.3yrs
CEO 소유권0.2%
경영진 평균 재임 기간4yrs
이사회 평균 재임 기간4.8yrs

최근 관리 업데이트

Recent updates

Analysts Just Slashed Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Numbers

Nov 13
Analysts Just Slashed Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Numbers

Here's Why Assembly Biosciences (NASDAQ:ASMB) Must Use Its Cash Wisely

Aug 17
Here's Why Assembly Biosciences (NASDAQ:ASMB) Must Use Its Cash Wisely

Will Assembly Biosciences (NASDAQ:ASMB) Spend Its Cash Wisely?

Feb 27
Will Assembly Biosciences (NASDAQ:ASMB) Spend Its Cash Wisely?

We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Nov 09
We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Jason Okazaki to succeed John McHutchison as Assembly Biosciences CEO at year-end

Oct 05

Assembly Biosciences to discontinue development of inhibitor vebicorvir, cut workforce

Jul 20

We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Jun 08
We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Jan 11
We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

We're Keeping An Eye On Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Sep 03
We're Keeping An Eye On Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Assembly Biosciences announces resignation of CFO

Jun 02

Time To Worry? Analysts Just Downgraded Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Outlook

Mar 24
Time To Worry? Analysts Just Downgraded Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Outlook

Assembly Biosciences' (NASDAQ:ASMB) Shareholders Are Down 86% On Their Shares

Feb 05
Assembly Biosciences' (NASDAQ:ASMB) Shareholders Are Down 86% On Their Shares

We're Hopeful That Assembly Biosciences (NASDAQ:ASMB) Will Use Its Cash Wisely

Dec 14
We're Hopeful That Assembly Biosciences (NASDAQ:ASMB) Will Use Its Cash Wisely

Assembly Bio inks deal with Door Pharmaceuticals to develop HBV core protein modulators

Nov 16

Assembly Biosciences EPS beats by $0.69, beats on revenue

Nov 05

CEO 보상 분석

Jason Okazaki 의 보수는 Assembly Biosciences 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$41m

Jun 30 2024n/an/a

-US$46m

Mar 31 2024n/an/a

-US$51m

Dec 31 2023US$1mUS$600k

-US$61m

Sep 30 2023n/an/a

-US$73m

Jun 30 2023n/an/a

-US$81m

Mar 31 2023n/an/a

-US$89m

Dec 31 2022US$2mUS$555k

-US$93m

Sep 30 2022n/an/a

-US$131m

Jun 30 2022n/an/a

-US$127m

Mar 31 2022n/an/a

-US$126m

Dec 31 2021US$1mUS$533k

-US$130m

Sep 30 2021n/an/a

-US$109m

Jun 30 2021n/an/a

-US$94m

Mar 31 2021n/an/a

-US$63m

Dec 31 2020US$4mUS$394k

-US$62m

보상 대 시장: Jason 의 총 보상 ($USD 1.37M )은 US 시장( $USD 652.28K ).

보상과 수익: Jason 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Jason Okazaki (48 yo)

2.3yrs

테뉴어

US$1,373,710

보상

Mr. Jason A. Okazaki serves as Chief Executive Officer and Director at Assembly Biosciences, Inc. since January 01, 2023. He served as Chief Operating Officer of Assembly Biosciences, Inc. since August 1,...

리더십 팀

이름위치테뉴어보상소유권
Jason Okazaki
CEO, President & Director2.3yrsUS$1.37m0.21%
$ 200.1k
William Delaney
Chief Scientific Officer3.8yrsUS$811.82k0.16%
$ 149.3k
Nicole White
Chief Manufacturing Officer4yrsUS$705.51k0.17%
$ 161.7k
Uri Lopatin
Co-Founder and Clinical & Scientific Advisor10.3yrsUS$1.50m데이터 없음
Adam Zlotnick
Co-Founderno data데이터 없음데이터 없음
Jeanette Bjorkquist
Executive Director of Accounting & Treasuryno data데이터 없음0.026%
$ 24.9k
Shannon Ryan
Senior Vice President of Investor Relationsno data데이터 없음데이터 없음
Jennifer Troia
Chief Human Resources Officer7yrs데이터 없음데이터 없음
Anuj Gaggar
Chief Medical Officerless than a year데이터 없음데이터 없음
Thomas Rollins
Executive Officer6.6yrsUS$652.02k데이터 없음
Amy Figueroa
Investor Relations Consultantno data데이터 없음데이터 없음

4.0yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: ASMB 의 관리팀은 경험 ( 4 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Jason Okazaki
CEO, President & Director1.8yrsUS$1.37m0.21%
$ 200.1k
Adam Zlotnick
Co-Founder10.3yrs데이터 없음데이터 없음
Anthony Altig
Independent Director12.8yrsUS$79.58k0.010%
$ 10.0k
William Ringo
Independent Non-Executive Chairman10.3yrsUS$122.08k0.023%
$ 21.9k
John McHutchison
Director5.3yrsUS$64.58k0.25%
$ 234.6k
Susan Mahony
Independent Director6.9yrsUS$74.58k0%
$ 0
Gina Consylman
Independent Director4.1yrsUS$72.08k0%
$ 0
Antonio Bertoletti
Member of Scientific Advisory Board4.8yrs데이터 없음데이터 없음
Edward Gane
Member of Scientific Advisory Board4.8yrs데이터 없음데이터 없음
Patrick Kennedy
Member of Scientific Advisory Board4.8yrs데이터 없음데이터 없음
Alex Thompson
Member of Scientific Advisory Board4.8yrs데이터 없음데이터 없음
Stephan Urban
Member of Scientific Advisory Board4.8yrs데이터 없음데이터 없음

4.8yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: ASMB 의 이사회는 경험(평균 재직 기간 4.8 년)으로 간주됩니다.